Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study
about
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.A working paradigm for the treatment of obesity in gastrointestinal practice.Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: Results of a prospective study.Exenatide has a Pronounced Effect on Energy Intake but not Energy Expenditure in Non-Diabetic Subjects with Obesity: A Randomized, Double-blind, Placebo-Controlled Trial.Burden of impaired sleep quality on work productivity in functional dyspepsia.
P2860
Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Exenatide in obesity with acce ...... omized, pharmacodynamics study
@ast
Exenatide in obesity with acce ...... omized, pharmacodynamics study
@en
type
label
Exenatide in obesity with acce ...... omized, pharmacodynamics study
@ast
Exenatide in obesity with acce ...... omized, pharmacodynamics study
@en
prefLabel
Exenatide in obesity with acce ...... omized, pharmacodynamics study
@ast
Exenatide in obesity with acce ...... omized, pharmacodynamics study
@en
P2093
P2860
P356
P1476
Exenatide in obesity with acce ...... omized, pharmacodynamics study
@en
P2093
Andres Acosta
Deborah Eckert
Duane Burton
Jessica O'Neill
Paula Carlson
P2860
P356
10.14814/PHY2.12610
P577
2015-11-01T00:00:00Z